SCHEMBL21168940

SCHEMBL21168940

c1ccc(-n2c3ccccc3c3cc4c5ccc6ccccc6c5n(-c5nc(-c6cccc7ccccc67)c6ccccc6n5)c4cc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
ATM Q13315 1/20 0.38
MAPT P10636 2/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
TUBB4A P04350 1/20 0.32
TUBB P07437 1/20 0.32
TUBA3C P0DPH7 1/20 0.32
TUBA1B P68363 1/20 0.32
TUBA4A P68366 1/20 0.32
TUBB4B P68371 1/20 0.32
TUBB3 Q13509 1/20 0.32
TUBB2A Q13885 1/20 0.32
TUBB8 Q3ZCM7 1/20 0.32
TUBA3E Q6PEY2 1/20 0.32
TUBA1A Q71U36 1/20 0.32
TUBA1C Q9BQE3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21168842 0.96 KDM4E (0.35) KDM4EL3MBTL1ATMMAPTCYP2C9
SCHEMBL21168894 0.92 KDM4E (0.36) KDM4EL3MBTL1ATMMAPTCYP2C9
SCHEMBL21168830 0.91 KDM4E (0.37) KDM4EL3MBTL1ATMMAPTMAPK1
SCHEMBL24104188 0.90 ALDH1A1 (0.37) KDM4EL3MBTL1ATMMAPTTUBB4A
SCHEMBL19636299 0.89 KDM4E (0.42) KDM4EL3MBTL1ATMMAPTMAPK1
SCHEMBL20048815 0.88 KDM4E (0.40) KDM4EL3MBTL1ATMMAPTCYP2C9
SCHEMBL21168816 0.88 KDM4E (0.40) KDM4EL3MBTL1ATMMAPTCYP2C9
SCHEMBL21577593 0.88 ALDH1A1 (0.36) KDM4EL3MBTL1ATMMAPTCYP2C9
SCHEMBL24027610 0.88 KDM4E (0.44) KDM4EL3MBTL1ATMMAPTCYP2C9
SCHEMBL19359934 0.88 KDM4E (0.41) KDM4EL3MBTL1ATMMAPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210328152-A1 ORGANIC ELECTROLUMINESCENT DEVICE ROHM & HAAS ELECT MATERIALS KOREA LTD (KR) 2021-10-21 US disclosed
US-20200058882-A1 ORGANIC ELECTROLUMINESCENT DEVICE ROHM & HAAS ELECT MATERIALS KOREA LTD (KR) 2020-02-20 US disclosed
US-20190355912-A1 ORGANIC ELECTROLUMINESCENT DEVICE ROHM & HAAS ELECT MATERIALS KOREA LTD (KR) 2019-11-21 US disclosed
US-20190221752-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190221752-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME EPCAM, OR10J3, L1CAM KDM4E 763/4885L3MBTL1 960/4885ATM 1583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.